A case of near-triploidy in myelodysplastic syndrome with del(5q) combined with del(1p) and del(13q)
- PMID: 22779072
- PMCID: PMC3384812
- DOI: 10.3343/alm.2012.32.4.294
A case of near-triploidy in myelodysplastic syndrome with del(5q) combined with del(1p) and del(13q)
Abstract
Numerical and structural chromosomal abnormalities are common in hematological malignancies. Near-triploidy (58-80 chromosomes) is a numerical abnormality observed in 3% of adult cases of acute lymphoblastic leukemia. Near-triploidy is rare in myeloid lineage hematologic malignancies and compared to near-triploidy in lymphoid malignancies, near-triploidy in myeloid malignancies is associated with poor outcomes. Few studies on near-triploidy in myelodysplastic syndrome (MDS) have been reported, and the clinicopathologic significance of this condition is still unclear. Here, we report a novel case of MDS with near-triploidy and multiple structural chromosomal abnormalities: del(5q) combined with del(1p) and del(13q). These abnormalities were detected by cytogenetic analysis with array comparative genomic hybridization (CGH). Our results suggest that array CGH can be a useful tool for detecting chromosomal abnormalities in patients with MDS.
Keywords: Array CGH; Myelodysplastic syndrome; Near-triploidy.
Conflict of interest statement
No potential conflicts of interest relevant to this article were reported.
Figures


Similar articles
-
Genomic Copy Number Variations in the Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients with del(5q) and/or -7/del(7q).Int J Med Sci. 2015 Sep 1;12(9):719-26. doi: 10.7150/ijms.12612. eCollection 2015. Int J Med Sci. 2015. PMID: 26392809 Free PMC article.
-
Cytogenetic and molecular predictors of response in patients with myeloid malignancies without del[5q] treated with lenalidomide.J Hematol Oncol. 2012 Mar 5;5:4. doi: 10.1186/1756-8722-5-4. J Hematol Oncol. 2012. PMID: 22390313 Free PMC article.
-
The 5q deletion size in myeloid malignancies is correlated to additional chromosomal aberrations and to TP53 mutations.Genes Chromosomes Cancer. 2016 Oct;55(10):777-85. doi: 10.1002/gcc.22377. Epub 2016 Jul 4. Genes Chromosomes Cancer. 2016. PMID: 27218649
-
Loss of 5q in myeloid malignancies - A gain in understanding of biological and clinical consequences.Blood Rev. 2021 Mar;46:100735. doi: 10.1016/j.blre.2020.100735. Epub 2020 Jul 23. Blood Rev. 2021. PMID: 32736878 Review.
-
New complex t(2;11;17)(p21;q23;q11), a variant form of t(2;11), associated with del(5)(q23q32) in myelodysplastic syndrome-derived acute myeloblastic leukemia.Cancer Genet Cytogenet. 2002 Sep;137(2):119-23. doi: 10.1016/s0165-4608(02)00564-2. Cancer Genet Cytogenet. 2002. PMID: 12393282 Review.
References
-
- Sabattini E, Bacci F, Sagramoso C, Pileri SA. WHO classification of tumours of haematopoietic and lymphoid tissues. Pathologica. 2010;102:83–87. - PubMed
-
- Solé F, Luño E, Sanzo C, Espinet B, Sanz GF, Cervera J, et al. Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes. Haematologica. 2005;90:1168–1178. - PubMed
-
- Le Beau MM, Albain KS, Larson RA, Vardiman JW, Davis EM, Blough RR, et al. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J Clin Oncol. 1986;4:325–345. - PubMed
-
- Stamatoullas A, Callat MP, Marreiros S, Tilly H, Bastard C. Unusual complex hyperdiploid karyotypes in myelodysplastic syndromes. Cancer Genet Cytogenet. 2006;170:129–132. - PubMed
-
- Iyer RV, Sait SN, Matsui S, Block AW, Barcos M, Slack JL, et al. Massive hyperdiploidy and tetraploidy in acute myelocytic leukemia and myelodysplastic syndrome. Cancer Genet Cytogenet. 2004;148:29–34. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous